ProCE Banner Activity

MM17: Current Evidence on the Efficacy of Convalescent Plasma to Treat COVID-19

Multimedia
In this presentation, Professor Jens D. Lundgren discusses the theory behind using convalescent plasma to treat infectious disease and the current evidence and recommendations regarding its use to treat patients with COVID-19.

Released: September 11, 2020

Expiration: September 10, 2021

Share

Faculty

Jens D. Lundgren

Jens D. Lundgren, MD, DMSc

Professor
Rigshospital, University of Copenhagen
Director
Centre of Excellence for Health, Immunity and Infection (CHIP)
Rigshospital, University of Copenhagen
Copenhagen, Denmark

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Educational grant provided by

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Jens D. Lundgren, MD, DMSc

Professor
Rigshospital, University of Copenhagen
Director
Centre of Excellence for Health, Immunity and Infection (CHIP)
Rigshospital, University of Copenhagen
Copenhagen, Denmark

Jens D. Lundgren, MD, DMSc, has no relevant conflicts of interest to report.